RBC Capital Reiterates Outperform on HealthEquity, Maintains $75 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Sean Dodge has reiterated an Outperform rating on HealthEquity (NASDAQ:HQY) and maintained a $75 price target.
June 06, 2023 | 1:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital analyst Sean Dodge reiterates an Outperform rating on HealthEquity (NASDAQ:HQY) and maintains a $75 price target.
The Outperform rating and maintained $75 price target by RBC Capital analyst Sean Dodge indicate a positive outlook for HealthEquity's stock in the short term. This news is highly relevant and important for investors as it provides a professional opinion on the company's stock performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100